An Educational Opportunity for Clinicians Specializing in the Treatment of



CME credit can be awarded upon completion of all four modules of the Diabetes Formative Assessment. It has been determined that this online activity can be completed in 90 minutes.

Release Date: August 20, 2013

Expiration Date: August 20, 2015

Statement of Need

The online formative assessment aims to provide clinicians with current treatment guidelines and clinical data of available and emerging therapies to facilitate the implementation of individualized, comprehensive treatment strategies for patients with T2DM.

Accreditation and Credit Designation

Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Indiana UniversityIndiana University School of Medicine designates this enduring material for a maximum of 1.5AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


While it offers CME/CE credits, this activity is not intended to provide extensive training or certification in the field.

Target Audience

This educational activity is designed for physicians, nurses, pharmacists and other clinicians involved in the care of patients with diabetes.

Learning Objectives

Upon completion of this activity participants will be able to:

  • Employ risk assessment and screening tools for associated comorbidities in patients with T2DM

  • Implement comprehensive management strategies that lower the risk for microvascular and macrovascular complications in patients with T2DM

  • Evaluate the use of various treatments for T2DM to customize therapeutic approaches and guide patients to be more compliant of treatment

  • Consider the goals of glycemic control with T2DM patients and utilize evidence-based monitoring practices that help to improve treatment adherence and outcomes

  • Critically review scientific evidence for new and emerging treatment regimens in T2DM management


This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc., which was made possible, in part, through collaboration with Eli Lilly and Company.

This activity is supported by an educational grant from Bristol-Myers Squibb/AstraZeneca LP.

This activity is supported by an educational grant from Lilly USA, LLC.  For further information concerning Lilly grant funding visit

Sponsor Statement

Cosponsored by Indiana University School of Medicine and The Academy for Continued Healthcare Learning


The content for this activity was developed independently of the commercial supporters. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publishers or grantors.

This educational activity was planned and produced in accordance with the ACCME Essential Areas and Elements, Updated Criteria, Policies, and Standards for Commercial Support.Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

System Requirements

To participate in this activity, you must have an active internet connection, 256 MB of RAM or higher, and Adobe Flash Player 8.0 (or higher). This activity is best viewed on Internet Explorer 7.0 or higher, Safari 4.0 or higher or Firefox 3.0 or higher.  Adobe Reader is required to print certificates.